Researchers develop a new prodrug and localized drug delivery platform for selective treatment of cancer. A new collaborative study reports the discovery and application of a novel therapeutic strategy to selectively target EGFR and other kinases with controlled release in tumor microenvironments to improve therapeutic efficacy, with promising results.
A apuração publicada por phys.org vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A new collaborative study reports the discovery and application of a novel therapeutic strategy to selectively target EGFR and other kinases with controlled release in tumor microenvironments to improve therapeutic efficacy, with promising results. The research is published in Bioorganic Chemistry.
- Ponto de atenção: researchers.
- Ponto de atenção: develop.
- Ponto de atenção: prodrug.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Agro. Quando fizer sentido, a referência complementar pode ser acessada em produtos do campo.